AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

iDNA Genomics Public Ltd

Share Issue/Capital Change Mar 1, 2023

2513_iss_2023-03-01_215f12c8-6a65-4fe8-a735-c013ef9dee96.pdf

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

iDNA GENOMICS PUBLIC LTD

Registered Office: 6 THEOTOKIS, 3RD FLOOR, 1055 NICOSIA, CYPRUS Registration Number: 415277

1 st March 2023

Mr. Nikos Tripatsas Acting General Manager Cyprus Stock Exchange Nicosia

ANNOUNCEMENT

Topic: Issuance and allotment of corporate bonds of IDNA Genomics Public Ltd

With the present, iDNA Genomics Public Ltd (the "Company") would like to inform the investing public that,

  • (a) pursuant to the decisions of the Extraordinary General Meeting of the shareholders of the Company, held on the 29th of December 2023, for the issuance of up to 6.000 convertible 8,5%, unsecured, non-guaranteed, 5-year bonds of nominal value €1.000 each (the "Bond"), and
  • (b) following a private placement to a limited number of persons,

the Board of Directors of the Company (the "Board") decided the issuance and allotment of 700 Bonds and total value €700.000, being the first tranche.

The Board will take all necessary actions for the listing of the Bond to the Bond Market of the Emerging Companies Market of the Cyprus Stock Exchange.

The Company may issue additional tranches of the Bond up until the 28th of December 2023, bringing the total value of the Bond to up to €6.000.000 (six million EUR).

Kind regards,

Prusec Limited Secretary on behalf of the Board of Directors

Talk to a Data Expert

Have a question? We'll get back to you promptly.